カテゴリ： Market Monitor Global, 世界, 医療/バイオ

結核（TB）用BCGワクチンのグローバル市場展望 2023年-2029年：免疫用、治療用

■ 英語タイトル：BCG Vaccine for Tuberculosis (TB) Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5709）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5709
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：114
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[結核（TB）用BCGワクチンのグローバル市場展望 2023年-2029年：免疫用、治療用]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の結核（TB）用BCGワクチン市場規模と予測を収録しています。・世界の結核（TB）用BCGワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の結核（TB）用BCGワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の結核（TB）用BCGワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫用」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

結核（TB）用BCGワクチンのグローバル主要企業は、Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVACなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、結核（TB）用BCGワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の結核（TB）用BCGワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の結核（TB）用BCGワクチン市場：タイプ別市場シェア、2022年
・免疫用、治療用

世界の結核（TB）用BCGワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の結核（TB）用BCGワクチン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の結核（TB）用BCGワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の結核（TB）用BCGワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における結核（TB）用BCGワクチンのグローバル売上、2018年-2023年
・主要企業における結核（TB）用BCGワクチンのグローバル売上シェア、2022年
・主要企業における結核（TB）用BCGワクチンのグローバル販売量、2018年-2023年
・主要企業における結核（TB）用BCGワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC

*************************************************************

・調査・分析レポートの概要
結核（TB）用BCGワクチン市場の定義
市場セグメント
世界の結核（TB）用BCGワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の結核（TB）用BCGワクチン市場規模
世界の結核（TB）用BCGワクチン市場規模：2022年 VS 2029年
世界の結核（TB）用BCGワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの結核（TB）用BCGワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の結核（TB）用BCGワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫用、治療用
結核（TB）用BCGワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
結核（TB）用BCGワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別結核（TB）用BCGワクチン市場規模 2022年と2029年
地域別結核（TB）用BCGワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC
...

BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Tuberculosis (TB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine for Tuberculosis (TB). This report contains market size and forecasts of BCG Vaccine for Tuberculosis (TB) in global, including the following market information:
Global BCG Vaccine for Tuberculosis (TB) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global BCG Vaccine for Tuberculosis (TB) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five BCG Vaccine for Tuberculosis (TB) companies in 2022 (%)
The global BCG Vaccine for Tuberculosis (TB) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine for Tuberculosis (TB) include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCG Vaccine for Tuberculosis (TB) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG Vaccine for Tuberculosis (TB) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Type, 2022 (%)
Immune Type
Therapy Type
Global BCG Vaccine for Tuberculosis (TB) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global BCG Vaccine for Tuberculosis (TB) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine for Tuberculosis (TB) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies BCG Vaccine for Tuberculosis (TB) revenues share in global market, 2022 (%)
Key companies BCG Vaccine for Tuberculosis (TB) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies BCG Vaccine for Tuberculosis (TB) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of BCG Vaccine for Tuberculosis (TB), market overview.
Chapter 2: Global BCG Vaccine for Tuberculosis (TB) market size in revenue and volume.
Chapter 3: Detailed analysis of BCG Vaccine for Tuberculosis (TB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of BCG Vaccine for Tuberculosis (TB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global BCG Vaccine for Tuberculosis (TB) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 BCG Vaccine for Tuberculosis (TB) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCG Vaccine for Tuberculosis (TB) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCG Vaccine for Tuberculosis (TB) Overall Market Size
2.1 Global BCG Vaccine for Tuberculosis (TB) Market Size: 2022 VS 2029
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global BCG Vaccine for Tuberculosis (TB) Sales: 2018-2029
3 Company Landscape
3.1 Top BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.2 Top Global BCG Vaccine for Tuberculosis (TB) Companies Ranked by Revenue
3.3 Global BCG Vaccine for Tuberculosis (TB) Revenue by Companies
3.4 Global BCG Vaccine for Tuberculosis (TB) Sales by Companies
3.5 Global BCG Vaccine for Tuberculosis (TB) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 BCG Vaccine for Tuberculosis (TB) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.8.1 List of Global Tier 1 BCG Vaccine for Tuberculosis (TB) Companies
3.8.2 List of Global Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global BCG Vaccine for Tuberculosis (TB) Market Size Markets, 2022 & 2029
4.1.2 Immune Type
4.1.3 Therapy Type
4.2 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
4.2.1 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2023
4.2.2 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2024-2029
4.2.3 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
4.3 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
4.3.1 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales, 2018-2023
4.3.2 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales, 2024-2029
4.3.3 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
4.4 By Type – Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global BCG Vaccine for Tuberculosis (TB) Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
5.2.1 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2023
5.2.2 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2024-2029
5.2.3 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
5.3 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
5.3.1 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales, 2018-2023
5.3.2 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales, 2024-2029
5.3.3 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
5.4 By Application – Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global BCG Vaccine for Tuberculosis (TB) Market Size, 2022 & 2029
6.2 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
6.2.1 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2023
6.2.2 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2024-2029
6.2.3 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
6.3 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
6.3.1 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales, 2018-2023
6.3.2 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales, 2024-2029
6.3.3 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.4.2 By Country – North America BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.4.3 US BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.4.4 Canada BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.4.5 Mexico BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.5.2 By Country – Europe BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.5.3 Germany BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.4 France BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.5 U.K. BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.6 Italy BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.7 Russia BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.8 Nordic Countries BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.9 Benelux BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.6.2 By Region – Asia BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.6.3 China BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.4 Japan BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.5 South Korea BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.6 Southeast Asia BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.7 India BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.7.2 By Country – South America BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.7.3 Brazil BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.7.4 Argentina BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.8.3 Turkey BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8.4 Israel BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8.5 Saudi Arabia BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8.6 UAE BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.2.4 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Key News & Latest Developments
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Company Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.3.5 Japan BCG Lab Key News & Latest Developments
7.4 China National Biotec
7.4.1 China National Biotec Company Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.4.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.4.5 China National Biotec Key News & Latest Developments
7.5 AJ Vaccines
7.5.1 AJ Vaccines Company Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.5.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.5.5 AJ Vaccines Key News & Latest Developments
7.6 Serum Institute of India
7.6.1 Serum Institute of India Company Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.6.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute of India Key News & Latest Developments
7.7 Intervax
7.7.1 Intervax Company Summary
7.7.2 Intervax Business Overview
7.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.7.4 Intervax BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.7.5 Intervax Key News & Latest Developments
7.8 GSBPL
7.8.1 GSBPL Company Summary
7.8.2 GSBPL Business Overview
7.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.8.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.8.5 GSBPL Key News & Latest Developments
7.9 Statens Serum Institute
7.9.1 Statens Serum Institute Company Summary
7.9.2 Statens Serum Institute Business Overview
7.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.9.4 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.9.5 Statens Serum Institute Key News & Latest Developments
7.10 Biomed Lublin
7.10.1 Biomed Lublin Company Summary
7.10.2 Biomed Lublin Business Overview
7.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.10.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.10.5 Biomed Lublin Key News & Latest Developments
7.11 ANLIS Malbran
7.11.1 ANLIS Malbran Company Summary
7.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Business Overview
7.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.11.5 ANLIS Malbran Key News & Latest Developments
7.12 Fundação Ataulpho de Paiva
7.12.1 Fundação Ataulpho de Paiva Company Summary
7.12.2 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Business Overview
7.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.12.5 Fundação Ataulpho de Paiva Key News & Latest Developments
7.13 BB-NCIPD
7.13.1 BB-NCIPD Company Summary
7.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Business Overview
7.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.13.5 BB-NCIPD Key News & Latest Developments
7.14 Taj Pharmaceuticals
7.14.1 Taj Pharmaceuticals Company Summary
7.14.2 Taj Pharmaceuticals Business Overview
7.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.14.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.14.5 Taj Pharmaceuticals Key News & Latest Developments
7.15 Bio Farma
7.15.1 Bio Farma Company Summary
7.15.2 Bio Farma Business Overview
7.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.15.4 Bio Farma BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.15.5 Bio Farma Key News & Latest Developments
7.16 Microgen
7.16.1 Microgen Company Summary
7.16.2 Microgen Business Overview
7.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.16.4 Microgen BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.16.5 Microgen Key News & Latest Developments
7.17 Torlakinstitut
7.17.1 Torlakinstitut Company Summary
7.17.2 Torlakinstitut Business Overview
7.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.17.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.17.5 Torlakinstitut Key News & Latest Developments
7.18 Institut Pasteur de Tunis
7.18.1 Institut Pasteur de Tunis Company Summary
7.18.2 Institut Pasteur de Tunis Business Overview
7.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.18.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.18.5 Institut Pasteur de Tunis Key News & Latest Developments
7.19 IVAC
7.19.1 IVAC Company Summary
7.19.2 IVAC Business Overview
7.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.19.4 IVAC BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.19.5 IVAC Key News & Latest Developments
8 Global BCG Vaccine for Tuberculosis (TB) Production Capacity, Analysis
8.1 Global BCG Vaccine for Tuberculosis (TB) Production Capacity, 2018-2029
8.2 BCG Vaccine for Tuberculosis (TB) Production Capacity of Key Manufacturers in Global Market
8.3 Global BCG Vaccine for Tuberculosis (TB) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BCG Vaccine for Tuberculosis (TB) Supply Chain Analysis
10.1 BCG Vaccine for Tuberculosis (TB) Industry Value Chain
10.2 BCG Vaccine for Tuberculosis (TB) Upstream Market
10.3 BCG Vaccine for Tuberculosis (TB) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 BCG Vaccine for Tuberculosis (TB) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • BCG&結核ワクチンのグローバル市場展望 2023年-2029年：免疫ワクチン、治療ワクチン
  • 麻疹・風疹（MR）ワクチンのグローバル市場展望 2023年-2029年：MRワクチン、MRBEVワクチン
  • 経口ワクチンアジュバントのグローバル市場展望 2023年-2029年：動物用ワクチンアジュバント、人間用ワクチンアジュバント
  • おたふく風邪ワクチンのグローバル市場展望 2023年-2029年：子供、大人
  • カルメットゲラン桿菌ワクチンのグローバル市場展望 2023年-2029年：免疫用、治療用
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5709 )"結核（TB）用BCGワクチンのグローバル市場展望 2023年-2029年：免疫用、治療用" (英文：BCG Vaccine for Tuberculosis (TB) Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。